| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 42.5087 | 15 |
| GSM780708 | Untreated after 4 days (C2_1) | 45.926 | 32 |
| GSM780709 | Untreated after 4 days (C3_1) | 44.7546 | 26 |
| GSM780719 | Untreated after 4 days (C1_2) | 49.5814 | 47 |
| GSM780720 | Untreated after 4 days (C2_2) | 47.4495 | 39 |
| GSM780721 | Untreated after 4 days (C3_2) | 41.3067 | 10 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 45.1751 | 28 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 46.6225 | 35 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 42.6819 | 16 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 47.6491 | 40 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 51.5688 | 53 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 54.5474 | 59 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 40.3676 | 7 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.3199 | 34 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 47.689 | 40 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 44.2279 | 23 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 47.02 | 37 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 49.7523 | 48 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 46.9308 | 36 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 46.8722 | 36 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 52.3083 | 55 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 45.773 | 31 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 49.4819 | 47 |